These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3802086)

  • 1. Tolerance of previously irradiated mouse kidneys to cis-diamminedichloroplatinum(II).
    Stewart FA; Luts A; Begg AC
    Cancer Res; 1987 Feb; 47(4):1016-21. PubMed ID: 3802086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal damage in mice after treatment with cisplatin and x-rays: comparison of fractionated and single-dose studies.
    Stewart FA; Luts A; Oussoren Y; Begg AC; Dewit L; Bartelink H
    NCI Monogr; 1988; (6):23-7. PubMed ID: 3352770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The response of previously irradiated skin to combinations of fractionated X radiation, hyperthermia, and cis-diamminedichloroplatinum.
    Baker DG; Sager H; Constable W; Goodchild N
    Radiat Res; 1984 Apr; 98(1):176-81. PubMed ID: 6538984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Residual damage in mouse lungs at long intervals after cyclophosphamide treatment.
    Travis EL; Bucci L; Fang MZ
    Cancer Res; 1990 Apr; 50(7):2139-45. PubMed ID: 2317805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification by cis-diamminedichloroplatinum (II) of the radiation dose-response curve for intestinal crypt cells in mice.
    Dewit L; Oussoren Y; Hart G
    Radiat Res; 1987 Sep; 111(3):445-56. PubMed ID: 3659279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Residual radiation-induced damage to the kidney of the pig as assayed by retreatment.
    Robbins ME; Bywaters T; Rezvani M; Golding SJ; Hopewell JW
    Int J Radiat Biol; 1991 Dec; 60(6):917-28. PubMed ID: 1682404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective protection against cis-diamminedichloroplatinum(II)-induced toxicity in kidney, gut, and bone marrow by diethyldithiocarbamate.
    Bodenner DL; Dedon PC; Keng PC; Katz JC; Borch RF
    Cancer Res; 1986 Jun; 46(6):2751-5. PubMed ID: 3009000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of cisplatin on the response of mouse kidneys to multifraction irradiation.
    Stewart FA; Oussoren Y; Bartelink H
    Radiother Oncol; 1989 May; 15(1):93-102. PubMed ID: 2748946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal damage in mice after treatment with cisplatinum alone or in combination with X-irradiation.
    Stewart F; Bohlken S; Begg A; Bartelink H
    Int J Radiat Oncol Biol Phys; 1986 Jun; 12(6):927-33. PubMed ID: 2941399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unilateral nephrectomy 24 hours after bilateral kidney irradiation reduces damage to the function and structure of the remaining kidney.
    Liao ZX; Travis EL
    Radiat Res; 1994 Sep; 139(3):290-9. PubMed ID: 8073111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of lethal and renal toxicity of cis-diamminedichloroplatinum(II) by induction of metallothionein synthesis without compromising its antitumor activity in mice.
    Naganuma A; Satoh M; Imura N
    Cancer Res; 1987 Feb; 47(4):983-7. PubMed ID: 3802104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of sequencing on combined toxicity of renal irradiation and cisplatin.
    Moulder JE; Fish BL
    NCI Monogr; 1988; (6):35-9. PubMed ID: 3352781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. cis-diamminedichloroplatinum(II) nephrotoxicity: tubular function after rescue with sodium diethyldithiocarbamate in rats.
    Elliott WC; Newcom SR; Houghton DC; Baines-Hunter J; Bennett WM
    Cancer Res; 1983 Aug; 43(8):3759-62. PubMed ID: 6305493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schedule-dependent therapeutic gain from the combination of fractionated irradiation and cis-diamminedichloroplatinum (II) in C3H/Km mouse model systems.
    Kanazawa H; Rapacchietta D; Kallman RF
    Cancer Res; 1988 Jun; 48(11):3158-64. PubMed ID: 2966671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the antiarrhythmic drug procainamide on the toxicity and antitumor activity of cis-diamminedichloroplatinum(II).
    Esposito M; Viale M; Vannozzi MO; Zicca A; Cadoni A; Merlo F; Gogioso L
    Toxicol Appl Pharmacol; 1996 Oct; 140(2):370-7. PubMed ID: 8887454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of cis-diamminedichloroplatinum and renal irradiation on renal function in the young and adult rat.
    Jongejan HT; van der Kogel AJ; Provoost AP; Molenaar JC
    Radiother Oncol; 1987 Sep; 10(1):49-57. PubMed ID: 3671772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selenium-induced protection against cis-diamminedichloroplatinum(II) nephrotoxicity in mice and rats.
    Baldew GS; van den Hamer CJ; Los G; Vermeulen NP; de Goeij JJ; McVie JG
    Cancer Res; 1989 Jun; 49(11):3020-3. PubMed ID: 2720662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of both cisplatin nephrotoxicity and drug resistance in murine bladder tumor by controlling metallothionein synthesis.
    Satoh M; Kloth DM; Kadhim SA; Chin JL; Naganuma A; Imura N; Cherian MG
    Cancer Res; 1993 Apr; 53(8):1829-32. PubMed ID: 8467502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequential functional testing of radiation-induced renal damage in the mouse.
    Williams MV; Denekamp J
    Radiat Res; 1983 May; 94(2):305-17. PubMed ID: 6856776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of glomerular von Willebrand factor after irradiation of the mouse kidney.
    van Kleef EM; te Poele JA; Oussoren YG; Verheij M; van de Pavert I; Braunhut SJ; Dewit LG; Stewart FA
    Radiat Res; 1998 Nov; 150(5):528-34. PubMed ID: 9806594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.